Engineering Anisotropic Meniscus: Zonal Functionality and Spatiotemporal Drug Delivery
Loading...
Identifiers
ISSN: 1937-3368
E-ISSN: 1937-3376
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Mary Ann Liebert
Abstract
Human meniscus is a fibrocartilaginous structure that is crucial for an adequate performance of the human knee joint. Degeneration of the meniscus is often followed by partial or total meniscectomy, which enhances the risk of developing knee osteoarthritis. The lack of a satisfactory treatment for this condition has triggered a major interest in drug delivery (DD) and tissue engineering (TE) strategies intended to restore a bioactive and fully functional meniscal tissue. The aim of this review is to critically discuss the most relevant studies on spatiotemporal DD and TE, aiming for a multizonal meniscal reconstruction. Indeed, the development of meniscal tissue implants should involve a provision for adequate active molecules and scaffold features that take into account the anisotropic ultrastructure of human meniscus. This zonal differentiation is reflected in the meniscus biochemical composition, collagen fiber arrangement, and cell distribution. In this sense, it is expected that a proper combination of advanced DD and zonal TE strategies will play a key role in the future trends in meniscus regeneration
Description
The authors acknowledge the original source of publication. Final publication is available
from Mary Ann Liebert, Inc.: http://dx.doi.org/10.1089/ten.teb.2020.0096
Bibliographic citation
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
http://hdl.handle.net/10347/23900
Requires
Publisher version
https://doi.org/10.1089/ten.teb.2020.0096Sponsors
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 814444 (MEFISTO); and from Xunta de Galicia’s Grupos de referencia competitiva (grant number ED431C 2017/09)
Rights
Copyright 2020, Mary Ann Liebert, Inc., publishers.








